- Home
- SER vs ZYXI Comparison
SER vs ZYXI Comparison
Compare SER & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SER
- ZYXI
- Stock Information
- Founded
- SER 2017
- ZYXI 1996
- Country
- SER United States
- ZYXI United States
- Employees
- SER N/A
- ZYXI N/A
- Industry
- SER Biotechnology: Pharmaceutical Preparations
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SER Health Care
- ZYXI Health Care
- Exchange
- SER Nasdaq
- ZYXI Nasdaq
- Market Cap
- SER 42.0M
- ZYXI 35.8M
- IPO Year
- SER 2018
- ZYXI N/A
- Fundamental
- Price
- SER $3.88
- ZYXI $0.62
- Analyst Decision
- SER Strong Buy
- ZYXI Hold
- Analyst Count
- SER 2
- ZYXI 3
- Target Price
- SER $13.00
- ZYXI $3.00
- AVG Volume (30 Days)
- SER 20.8K
- ZYXI 6.0M
- Earning Date
- SER 11-13-2025
- ZYXI 11-17-2025
- Dividend Yield
- SER N/A
- ZYXI N/A
- EPS Growth
- SER N/A
- ZYXI N/A
- EPS
- SER N/A
- ZYXI N/A
- Revenue
- SER $116,000.00
- ZYXI $108,202,000.00
- Revenue This Year
- SER $134.46
- ZYXI N/A
- Revenue Next Year
- SER N/A
- ZYXI $7.07
- P/E Ratio
- SER N/A
- ZYXI N/A
- Revenue Growth
- SER N/A
- ZYXI N/A
- 52 Week Low
- SER $3.70
- ZYXI $0.38
- 52 Week High
- SER $7.92
- ZYXI $8.72
- Technical
- Relative Strength Index (RSI)
- SER 39.43
- ZYXI 33.14
- Support Level
- SER $3.73
- ZYXI $0.38
- Resistance Level
- SER $4.12
- ZYXI $0.74
- Average True Range (ATR)
- SER 0.31
- ZYXI 0.15
- MACD
- SER -0.01
- ZYXI -0.05
- Stochastic Oscillator
- SER 23.99
- ZYXI 28.94
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.